NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/24/2026
Back to search
Official data from USPTO
RENAGADE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
69
Latest update
03/25/2026
Trademark type
Word
Nice classes
5
Filing date
02/24/2021
Registration date
03/24/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/24/2026
Last transaction
03/25/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2022-11-00
First use in commerce
2022-11-00
Drawing code
4
Owner type
16
Owner location
Watertown, MA, US
Examiner
PETTICAN, NATHANIEL VINCIENT
Law office
L80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Renagade Therapeutics LLC
Renagade Therapeutics LLC
Representatives
Jonathan M. Gelchinsky Pierce Atwood LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and substancesRNA therapeutics for the treatment of infectious diseasesblood disordersinflammation; pharmaceutical preparationsRNA therapeutics for the prevention of cancersinflammatory disordersimmunoregulatory disordersinfectious disorders; pharmaceutical preparationsRNA therapeutics for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparationsRNA therapeutics for the treatment of viral infections; pharmaceutical preparationsRNA therapeutics for the treatment of cancersinflammatory disordersimmunoregulatory disordersinfectious disorders; pharmaceutical preparationsRNA therapeutics for use in chemotherapy; pharmaceutical preparationsRNA therapeutics for cancersinflammatory disordersimmunoregulatory disordersinfectious disorders; pharmaceutical preparationsantivirals; therapeutic pharmaceuticalsRNA therapeutics for the treatment of cancersinflammatory disordersimmunoregulatory disordersinfectious disorders; vaccine preparationsRNA vaccine preparations; vaccinesRNA vaccines; human vaccine preparationsRNA vaccine preparations; medical preparations for the treatment of cancersinflammatory disordersimmunoregulatory disordersinfectious disorders; medicinal preparations for the treatment of infectious diseases and for use in oncology; mixed biological preparationsRNA therapeutics for the prevention and treatment of infectious diseases; pharmaceutical preparationsRNA therapeutics for the prevention and treatment of autoimmune diseases or disorders; pharmaceutical preparations for the treatment of viral diseases; pharmaceutical productsRNA therapeutics for the treatment of viral and infectious diseasesfor the treatment of cancer; therapeutic vaccinesRNA therapeutics; all of the foregoing excluding medicinal dietary and nutritional supplements
Publications
History of USPTO decisions and trademark events.
69 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/24/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/05/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/05/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/05/2026
IUAF
USE AMENDMENT FILED
03/04/2026
EISU
TEAS STATEMENT OF USE RECEIVED
03/04/2026
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/29/2025
EX5G
SOU EXTENSION 5 GRANTED
12/29/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/29/2025
EXT5
SOU EXTENSION 5 FILED
08/11/2025
EEXT
SOU TEAS EXTENSION RECEIVED
08/11/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/13/2025
EX4G
SOU EXTENSION 4 GRANTED
02/13/2025
EXT4
SOU EXTENSION 4 FILED
02/12/2025
EEXT
SOU TEAS EXTENSION RECEIVED
02/12/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/04/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/04/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/04/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/04/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/04/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/30/2024
EX3G
SOU EXTENSION 3 GRANTED
08/30/2024
EXT3
SOU EXTENSION 3 FILED
08/30/2024
EEXT
SOU TEAS EXTENSION RECEIVED
08/30/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/30/2024
EX2G
SOU EXTENSION 2 GRANTED
01/26/2024
EXT2
SOU EXTENSION 2 FILED
01/26/2024
EEXT
SOU TEAS EXTENSION RECEIVED
01/26/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/14/2023
EX1G
SOU EXTENSION 1 GRANTED
04/12/2023
EXT1
SOU EXTENSION 1 FILED
04/12/2023
EEXT
SOU TEAS EXTENSION RECEIVED
04/12/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/14/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/17/2023
PUBO
PUBLISHED FOR OPPOSITION
01/17/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/28/2022
EXPT
EXPARTE APPEAL TERMINATED
12/21/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/14/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/14/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/14/2022
ALIE
ASSIGNED TO LIE
11/14/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
11/04/2022
EXPI
EX PARTE APPEAL-INSTITUTED
11/04/2022
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
11/04/2022
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
11/04/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/13/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/13/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/13/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/13/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/13/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
05/04/2022
GNFR
FINAL REFUSAL E-MAILED
05/04/2022
CNFR
FINAL REFUSAL WRITTEN
05/04/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/31/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/31/2022
ALIE
ASSIGNED TO LIE
03/31/2022
NREV
NOTICE OF REVIVAL - E-MAILED
03/30/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/29/2022
PETG
PETITION TO REVIVE-GRANTED
03/29/2022
PROA
TEAS PETITION TO REVIVE RECEIVED
03/29/2022
MAB2
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
03/29/2022
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
03/29/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/15/2021
GNRT
NON-FINAL ACTION E-MAILED
09/15/2021
CNRT
NON-FINAL ACTION WRITTEN
09/15/2021
DOCK
ASSIGNED TO EXAMINER
09/15/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/26/2021
NWAP
NEW APPLICATION ENTERED
02/27/2021
Continuous trademark protection
Get notified about every new filing that threatens RENAGADE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.